Impact of targeted therapy on outcome of chronic lymphocytic leukemia patients with relapsed del(17p13.1) karyotype at a single center

Saved in:

Bibliographic Details
Published in:	Leukemia Vol. 28; no. 6; pp. 1365 - 1368
Main Authors:	Stephens, D M, Ruppert, A S, Jones, J A, Woyach, J, Maddocks, K, Jaglowski, S M, Andritsos, L A, Flynn, J M, Grever, M R, Lozanski, G, Johnson, A J, Muthusamy, N, Heerema, N A, Byrd, J C
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 01-06-2014 Nature Publishing Group
Subjects:	692/699/67/1059/602 692/699/67/1990/283/1895 Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Blood Cancer Research Care and treatment Chromosome Deletion Chromosomes, Human, Pair 17 - genetics Chronic lymphocytic leukemia Creatinine Critical Care Medicine Female Follow-Up Studies Genetic aspects Hematology Humans In Situ Hybridization, Fluorescence Intensive Internal Medicine Karyotypes Karyotyping letter-to-the-editor Letters to the editor Leukemia Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy Leukemia, Lymphocytic, Chronic, B-Cell - genetics Leukemia, Lymphocytic, Chronic, B-Cell - mortality Lymphatic leukemia Male Medical prognosis Medicine Medicine & Public Health Middle Aged Molecular Targeted Therapy Mutation Neoplasm Recurrence, Local - drug therapy Neoplasm Recurrence, Local - genetics Neoplasm Recurrence, Local - mortality Neutropenia Oncology Patient outcomes Patients Physiological aspects Prognosis Survival Rate Tumor suppressor genes United States > US
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23
ISSN:	0887-6924 1476-5551
DOI:	10.1038/leu.2014.42